In October 2021 the International Tennis Federation (ITF) has reported an anti-doping rule violation against the Russian tennis player Daria Mishina after her sample tested positive for the prohibited substance Testosterone.
After notification the Athlete gave a prompt admission, waived her right for a hearing, accepted a provisional suspension and the sanction proposed by the ITF.
The Athlete accepted the test result and denied the intentional use of the substance. She explained with evidence that she underwent treatment in a Clinic for her medical condition.
She asserted that in this Clinic the medical staff accidentally must have mixed up two treatments. She had to receive a Vitamin D injection whereas another patient had to receive a Testosterone intravenous infusion.
The ITF considered that the administered intravenous infusion in the Clinic is a prohibited method and invited the Athlete to apply for a retroactive TUE. However the ITF TUE Committee rejected this application in August 2022.
Consequently in in December 2022 the ITF formally reported two anti-doping rule violations against the Athlete for the presence of Testosterone and for the use of a prohibited method. In view of the evidence The ITF deems that the Athlete had not demonstrated that the violation was not intentional and considers that she gave an early admission and acceptance of sanction.
Therefore the ITF decides on 17 February 2023 to impose a 3 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 16 October 2021
